Exposure of the cochlear implant electrode array as a late complication has been reported rarely in the literature. A retrospective analysis revealed 4 patients presenting with exposure of their cochlear implant electrode arrays from 2 to 17 years after implantation. Data collected from these 4 patients were surgical implantation approach, type of implant, age at implant, interval between implant and complication, surgical correction of the problem, pathology at the time of correction, and length of follow-up after intervention. All 4 patients presented with otitis or mastoiditis. Each had undergone a transmastoid approach with facial recess and cochleostomy and full implant insertion. In 3 cases, the tympanic membrane had retracted to expose the electrode array. In 1 patient, the electrode array had eroded through the external canal, lateral to the facial recess. The exposed arrays were addressed surgically, including explantation/reimplantation for 1 patient. Cochlear implant electrode arrays can become exposed by relative migration of the array and the tympanic membrane. Implant surgeons and audiologists need to be aware of the possibility of this complication. Closure of the ear canal appears to be the most effective surgical intervention.
Introduction
As cochlear implantation becomes more common, so do the numbers of surgical approaches for implantation. These include transmastoid with facial recess, suprameatal, and endoscopic placements, either transmastoid or via the external canal. [1] [2] [3] [4] Of these surgical options, the transmastoid approach with facial recess would appear to protect the electrode array, keeping it protected behind the bony external canal and positioned along the medial surface of the middle ear. Even with this conservative positioning of the electrode array, however, we have found that exposure can develop.
Review of the literature finds few reports of this problem. [5] [6] [7] [8] [9] [10] The discontinued cochlear implant positioner is reported twice to have spontaneously extruded from the basal turn through the tympanic membrane. 8, 11 Reports of cochlear implant electrode arrays becoming exposed in the context of a cholesteatoma, tympanic membrane perforation, retraction pockets, or medialization of the entire tympanic membrane appear in the literature. [5] [6] [7] [8] [9] [10] The 4 cases we report here add a fuller picture to this delayed complication so that audiologists and otologists can be more sensitive to the possibility of array exposure. They illustrate the range of time intervals from implantation to spontaneous exposure, the presenting symptoms, and the surgical interventions used.
Case series
This study was approved by our institution's Institutional Review Board. Four patients presented with their cochlear implant array exposed in their middle ear space or ear canal. No patient had a history of otitis or eustachian tube dysfunction. All were implanted via a traditional transmastoid facial recess technique. Two were implanted as children (ages 2 and 5 years). All patients presented to the audiologist or otologist with complaints of ear itching, pain, and drainage. One patient also had reduced implant performance as a concern. The time interval from implantation to array exposure ranged from 2 to 17 years. Patient 1. The first patient in this series was diagnosed with congenital sensorineural hearing loss and received an implant at age 2 via basic mastoidectomy with facial recess exposure of the round window niche, followed by cochleostomy. A Nucleus 22 Implant (Cochlear Limited; Sydney, Australia) was inserted fully, and the postoperative course was without complications. Initial stimulation was at 4 weeks postimplant.
Two episodes of acute otitis 17 years after implantation signaled the medialization of the patient's tympanic membrane with retraction into the aditus ad antrum and cholesteatoma formation. The electrode array was exposed across the entire middle ear space, but computed tomography (CT) revealed that the implant remained in good position even though the cholesteatoma filled the mastoid bowl.
In the operating room (OR), with a backup implant available in the room, the mastoidectomy was revised to remove all cholesteatoma and all epithelium from the mastoid, aditus, middle ear space, and medial ear canal. Extreme caution was exercised not to dislodge the implant. The external canal was oversewn in 2 layers, and a pedicled pericranial flap from the squamous temporal bone was interposed between the closure and the electrode array.
Intraoperative neural response telemetry (NRT) signals were intact, and plain anteroposterior (AP) film of the skull showed the implant still in good position; therefore, the implant program did not need to be modified postoperatively. Oral postoperative antibiotics were administered for 10 days. At 18 months' follow-up, the patient had no complaints. Patient 2. Our second patient was diagnosed with congenital sensorineural hearing loss and received an implant at age 5 via a transmastoid facial recess approach with cochleostomy. A Nucleus CI24M (Cochlear Limited) was fully inserted, and it was programmed 6 weeks later. Four years after implantation, she presented with otitis externa and drainage. Physical examination identified exposure of the electrode array through the skin and bone of the external auditory canal lateral to the annulus and tympanic membrane. This problem was corrected in the OR by removing the skin of the external canal and tympanic membrane and oversewing the external canal in 3 layers.
Extreme caution was exercised to not dislodge the implant as the external canal skin was removed. No backup implant was on hand, and no rotation of pedicled flaps or plain AP view of the skull was performed in the OR. However, NRT signals were intact on all electrodes in the OR, and postoperative implant performance was identical to preoperative performance. Postoperative oral antibiotics were given for 5 days. Follow-up 9 years later with physical examination and CT found implant performance to be unchanged. Patient 3. Patient 3 experienced two sequential episodes of sudden deafness and at age 42 received a Nucleus Freedom (Cochlear Limited) device via a transmastoid approach with facial recess and cochleostomy with full insertion. Initial stimulation found all electrodes active, and the patient's performance with the implant was excellent. However, he developed drainage from the right external auditory canal 2 years postoperatively. Physical examination uncovered a tympanic membrane that had medialized and an exposed electrode array.
A transcanal elevation of the tympanic membrane was performed with care not to dislodge the implant, and autologous fat was placed to fill the middle ear space and cover the electrode, followed by replacement of the tympanic membrane. No backup implant was on hand in the OR. Plain AP film of the skull showed the implant in good position, and NRT signals were present in the OR. Postoperative oral antibiotics were administered for 7 days.
Initially, the electrode array remained covered, but by 6 months the tympanic membrane had medialized and the electrode was exposed again. Performance with the implant remains unchanged, and the patient returns for examination every 4 months. At the 2-year follow-up, the patient remains without complaints, infection, or reduction of implant function.
Patient 4. Our fourth patient had progressive sensorineural hearing loss of undetermined etiology and received an implant at age 47 via a transmastoid, facial recess, cochleostomy approach. A Nucleus CI24R (Cochlear Limited) was fully inserted, an NRT signal was present in the OR, and performance postoperatively was excellent. Nine years later she presented with ear drainage and reduced hearing. NRT revealed that the basal electrodes appeared to be nonfunctional. On physical examination, the electrode array was visible on the tympanic membrane and an otitis media was present. The patient was treated with oral antibiotics and otic drops for 6 days, followed by surgical intervention.
In the OR, a deep retraction of the tympanic membrane into the facial recess was found, and this retraction appeared to be associated with the array exposure and the partial extrusion from the basal turn. A backup implant was available in the OR and the original was explanted, after which the backup was implanted. The skin of the tympanic membrane, the retraction pocket, and the medial external canal were removed.
The placement of the implanted device was confirmed by plain AP of the skull and NRT. The external canal was oversewn in two layers, and a pedicled pericranial flap from the squamous temporal bone was rotated to be interposed between the array and the closed ear canal. Postoperative oral antibiotics were given for 14 days.
Postoperative performance was superior to preoperative performance, and the map was modified to reactivate the basal electrodes. The patient remained without difficulties 1 year after reimplantation.
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Discussion
We report 3 cases of medialization of the tympanic membrane resulting in exposure of the cochlear implant electrode array, along with 1 case of the array eroding through the external bony canal. All of these patients had infections and drainage at the time of presentation. One complained of reduced implant function. These complications occurred 2 to 17 years after implantation, and they highlight the need for annual follow-up of patients who receive cochlear implants.
Similar complications have been reported previously. Changes of the anatomic relationships between the electrode array and the mastoid bone and soft tissue have occurred in a variety of situations, including exposures in 3 children with cholesteatoma and in 2 others with tympanic membrane retraction and granulation tissue. [5] [6] [7] [8] [9] [10] Children and adults have developed spontaneous, dry tympanic membrane perforations with exposure. 5 One adult had a retraction pocket that exposed the electrode array. 8 One study reports 3 of 7 spontaneous exposures as a result of erosion of the posterior external canal bone years postoperatively. 5 The time intervals until the arrays became exposed were 1 to 6 years after implantation. 5, 9, 10 These scenarios are similar to the 4 we present. It is unclear why the tympanic membrane starts to retract in patients who previously have had no evidence of eustachian tube dysfunction. It is also unclear what might be the mechanism of erosion of the electrode array through the external canal, as seen in our patient 2 and the 3 patients previously reported. 5 Perhaps inherent weakness or fissure of the external canal bone may be the cause, or perhaps it may be due to surgical thinning of the bone in the original implantation.
The presenting complaint is not recorded for most of the previous reports in the literature. Three patients presented with otalgia and 1 with hearing loss. 5, 9, 10 All of our patients presented with otitis. Only 1 complained of hearing loss.
Repairs described in the literature are with elevation of the tympanic membrane, removal of the retraction pocket, and reinforcement of the tympanic membrane reconstruction with cartilage grafts or mastoidectomy. 5, [8] [9] [10] Follow-up times for these repairs in 3 patients have been reported to be 3 weeks and 1 year. 5, 9, 10 In one series, 5 of 7 patients with exposed arrays did not undergo repair and were followed clinically for 2 to 6 years without any discernible complications. 5 None of these patients showed any otitis, however, before the decision was made to follow them without surgical intervention.
In our series, we found that reinforcing the middle ear space with fat and replacing the tympanic membrane was unsuccessful within 6 months (patient 3). This patient appeared to be free of complications 2 years after the failed attempt. Closure of the ear canal with interposition of a pedicled, vascularized graft seemed to keep the array covered (patients 2, 3, and 4) for the 1 to 9 years of follow-up for these 3 patients.
In these surgeries, every attempt is made to avoid dislodging the functioning implant by stabilizing the array with one hand while the soft tissue is removed from the array with the other hand. We now have a backup implant available during all of our soft-tissue revisions after cochlear implant in the event of unintended explantation. Although surgical correction of the exposure in the presence of tissue irritation and infection seems advisable, trapped epithelium and the formation or reformation of a cholesteatoma are possibilities with closure of the canal. The availability of a backup implant is a necessity during a second-look operation.
Our series adds to sparse reports in the literature. Even in a well-aerated ear and using the transmastoid approach to implantation, exposure of an electrode array can occur. A previously well-aerated middle ear can form retractions of the tympanic membrane that eventually expose the array. Retraction into the aditus ad antrum can cause cholesteatoma.
As has been observed in the 3 patients reported in the literature previously, the electrode array can even erode through the bony external canal, by a mechanism that is unclear. Our most successful repairs involved closing the external canal, although an argument can be made from reports in the literature for simply observing exposed arrays in an uninfected ear.
This series serves to illustrate that yearly implant inspection is worthwhile. In addition, any complaint of hearing change, pain, or drainage should be evaluated promptly. Audiologists and otologists should be aware of this particular complication.
